1.Targeting-YAP/TAZ therapies for head and neck cancer, directly or indirectly?
West China Journal of Stomatology 2021;39(5):493-500
YAP/TAZ are wild over-activated in head and neck squamous cell carcinoma (HNSCC) with high potential as a direct therapy target for HNSCC treatments. However, the efforts on the directly targeting-YAP/TAZ therapies over the past decade, have very limited impacts, mainly caused by: 1. There is still none effective and specific YAP/TAZ inhibitor with clinical potential; 2. YAP/TAZ might not be directly targeted, because of their multiple important biological functions, such as: regulation of cell proliferation and survival, stem cell maintain, regulation of organ development, organ size control, and tissue regeneration. Interestingly, the over-activation of YAP/TAZ in HNSCC mainly be regulated by upstream abnormal molecular or biological events, instead of genes alteration of YAP/TAZ. Therefore, exploring the alternative molecular events regulating YAP/TAZ activation and molecular mechanism in HNSCC might help to uncover novel indirect targets of YAP/TAZ therapies for HNSCC prevention and treatment.
Adaptor Proteins, Signal Transducing/metabolism*
;
Head and Neck Neoplasms
;
Humans
;
Phosphoproteins/metabolism*
;
Trans-Activators/metabolism*
;
Transcription Factors
2.Expressions of short palate, lung and nasal epithelium clone 1 in different human tissues.
Shuang WANG ; Wen-Lu LI ; Li-Chun LÜ ; Kai-Tai YAO
Journal of Southern Medical University 2016;36(5):617-621
OBJECTIVETo examine the expression patterns of short palate, lung and nasal epithelium clone 1 (SPLUNC1) gene in human tissues.
METHODSIn situ hybridization was used to detect the expression of SPLUNC1 gene in 37 different human tissues.
RESULTSWe found that SPLUNC1 gene was not expressed in squamous epithelial cells of the palate, epidermis, esophagus, or the esophagus-cardia junction, metaplastic squamous cells in the nasopharynx, trachea, or uterus cervix, or tumor cells of esophageal squamous cell carcinoma or lung squamous cell carcinoma. SPLUNC1 gene was not expressed in the single layer columnar epithelia cells in the stomach, gallbladder, jejunum, colon, endometrium, or uterus cervix. SPLUNC1 expression was detected mainly in pseudostratified columnar epithelial cells in the nasopharynx, trachea and bronchi, and was gradually down-regulated from the upper to lower end of the respiratory tract, but was not detected in the lung tissues. SPLUNC1 expression was detected not only in the duct and serous gland cells in the parotid and submandibular glands, but also in cells of submucosal serous glands in the nasopharynx and lung, but not in the cells of the mucosal glands. The parietal cells of the gastric submucosa and epithelial cells of the lobula and ducts of the mammary glands expressed SPLUNC1. The adenocarcinoma cells in the lung, stomach, colon, mammary gland, uterus endometrium and cervix showed strong expressions of SPLUNC1 gene.
CONCLUSIONSPLUNC1 expression is highly cell-specific in association with the cell functions.
Epithelial Cells ; metabolism ; Gene Expression ; Glycoproteins ; genetics ; metabolism ; Humans ; Organ Specificity ; Phosphoproteins ; genetics ; metabolism
3.Phosphoproteomics and its application in cancer research.
Journal of Central South University(Medical Sciences) 2008;33(7):559-564
Phosphoproteome is the whole complement of phosphorylated proteins in a cell, tissue or organism, and has become an interesting study subject since the discovery of phosphorylation as a key regulatory mechanism of cell life. Phosphoproteomics is a method which studies the compact of the phosphorylated proteins, expression and modification, interaction and association, rule of the regulatory and so on. Recently, phosphoproteomics is widely used in cancer research. It will provide important information in cancer research, cancer diagnosis, and therapy.
ErbB Receptors
;
genetics
;
Humans
;
Neoplasms
;
genetics
;
metabolism
;
Phosphoproteins
;
genetics
;
metabolism
;
Phosphorylation
;
Proteomics
;
methods
;
Signal Transduction
4.Expression of hRad21 and clinicopathological analysis in gastrointestinal malignant tumors maintained their telomeres by a mechanism of alternative lengthening of telomeres.
Bing-qiang YI ; Bo ZHAO ; Zhen-jun WANG
Chinese Journal of Gastrointestinal Surgery 2008;11(1):67-71
OBJECTIVETo investigate the proportion between tumors which maintain their telomeres by a mechanism of alternative lengthening of telomeres(ALT) and telomerase-dependent tumors in gastrointestinal malignant tumors, the expression difference of hRad21 between the two groups and the clinicopathological characteristics of ALT tumors were also explored.
METHODSOne hundred and four cases of gastrointestinal malignant tumors were divided into 2 groups: ALT group and telomerase group by detecting telomerase activity using TRAP method. Expression difference of hRad21 was investigated between the two groups. All the patients were followed up and clinicopathological data of these patients were analyzed.
RESULTSOf 104 cases, there were 12 cases in ALT group and 94 cases in telomerase group. Expression of hRad21 in ALT group was higher than that in telomerase group. Tumors in ALT group had a thinner invasion depth (lower T stage) as compared to telomerase group (P=0.021). Other indexes, such as age, gender, tumor size, tumor grade, location of tumor, CEA and CA199, were not significantly different between the two groups. Results of follow-up showed that the survival rate of ALT group was 100% while that of telomerase group was 56% at 30 months postoperatively.
CONCLUSIONSThere are tumors which maintain their telomeres by ALT in gastrointestinal malignant tumors, accounting for 10%-12% of the total tumors. As compared to telomerase group, ALT group presents higher expression of hRad21, thinner tumor invasion depth, and higher survival rate.
Female ; Gastrointestinal Neoplasms ; metabolism ; pathology ; Humans ; Male ; Neoplasm Invasiveness ; Nuclear Proteins ; metabolism ; Phosphoproteins ; metabolism ; Telomerase ; metabolism ; Telomere ; metabolism
5.Temporal expression of HCMV IE1 and pp65 in human glioma U(251) cells.
Jian-Hua LI ; Ying FU ; Li-Yu CHEN ; Gan DAI ; Min-Hua LUO ; Tao YANG
Journal of Central South University(Medical Sciences) 2007;32(4):551-556
OBJECTIVE:
To determine whether U(251) cells are permissive for human cytomegalovirus (HCMV), and to investigate the characteristics of temporal expression of proteins IE1 and pp65.
METHODS:
U(251) cells were infected with HCMV, and then the cells were observed under the transmission electronic microscope, and the viral nucleic acid was detected by PCR, and the expression levels of IE1 and pp65 were analyzed by immunohistochemical assay with anti-IE1 monoclonal antibody and anti-pp65 monoclonal antibody at various time spost infection.
RESULTS:
Morphological changes of the infected cells appeared under the transmission electron microscope. The viral nucleic acid was detected successfully by PCR. The expression of IE1 was detected firstly at 4h post infection, and reached a peak within 14h, and then decreased. The incoming pp65 was detected at 1h, the low expression levels of pp65 were detected firstly at 4h, and they could remain relatively constant through 96 h, but the maximum expression occurred at 120 h.
CONCLUSION
Human glioma U(251) cells are permissive for HCMV, the temporal cascade of HCMV gene expression can be observed in the infected U(251) cells, but it is delayed obviously in the human fibroblast.
Cell Line, Tumor
;
Cytomegalovirus
;
Cytomegalovirus Infections
;
Glioma
;
metabolism
;
virology
;
Humans
;
Immediate-Early Proteins
;
metabolism
;
Phosphoproteins
;
metabolism
;
Viral Matrix Proteins
;
metabolism
6.Expression of nucleolin in pressure overload-induced cardiac hypertrophy rats.
Simin YAN ; Shuang WU ; Li SUN ; Bimei JIANG ; Zizhi TU ; Xianzhong XIAO
Journal of Central South University(Medical Sciences) 2014;39(2):124-128
OBJECTIVE:
To detect the expression of nucleolin in cardiac hypertrophy rats induced by pressure overload.
METHODS:
A total of 40 SD rats with body weight 180 g and 220 g were recruited and randomly divided into 2 groups: a transverse aortic constriction (TAC) group and a sham surgery group. Cardiac hypertrophy model was employed by transverse aortic constriction surgery. Then 2 weeks and 4 weeks after the experiment, the heart mass index (HMI), left ventricle mass index (LVMI) were measured. β-MHC mRNA in the heart tissue was detected with RT-PCR. Nucleolin in the heart, brain and kidney was respectively detected with Western blot.
RESULTS:
Compared with the sham surgery group, HMI, LVMI in the TAC group increased significantly (P<0.01) 4 weeks after the surgery; the expression of β-MHC mRNA in the heart tissue increased (P<0.05) in the TAC group 4 weeks after the surgery; and the expression of nucleolin protein in the heart tissue of the TAC group was remarkably upregulated (P<0.05) 2 weeks after the surgery, with no change in the brain and kidney tissue between the 2 groups.
CONCLUSION
Expression of nucleolin protein has been upregulated in response to pressure overload, which may suggest that nucleolin plays a role in cardiac hypertrophy induced by pressure overload.
Animals
;
Blood Pressure
;
Cardiomegaly
;
metabolism
;
Myocardium
;
metabolism
;
Phosphoproteins
;
metabolism
;
RNA, Messenger
;
RNA-Binding Proteins
;
metabolism
;
Rats
;
Rats, Sprague-Dawley
7.Nucleolus expression in diabetic cardiomyopathy.
Li SUN ; Xin HE ; Juan WANG ; Bimei JIANG ; Zhongyi TONG ; Yanjuan LIU ; Yuanbin LI ; Xianzhong XIAO
Journal of Central South University(Medical Sciences) 2014;39(10):1056-1060
OBJECTIVE:
To investigate the nucleolus expression in the diabetic cardiomyopathy.
METHODS:
The rats were divided into a control group and a type II diabetic cardiomyopathy group (model group). In the model group, rats were fed with high-fat and high-sugar food (rats were intravenously injected with 60 mg/kg chain urea with cephalosporins in the 5th and 6th weeks in mice). The level of blood glucose was determined at the end of 8th week and the level of fasting blood glucose was examined at the end of 20th week. The ratio of the heart mass and body mass was calculated, and the pathological changes in myocardial morphology were observed. The immunohistochemical method and Western blot were used to detect the expression level of myocardial nucleolin.
RESULTS:
The level of fasting blood glucose was significantly increased in the diabetic model group than that in the control group (P<0.05). Rats in the model group were found hypertrophic cardic cells, with fracture, dissolusion, and disordered arrangement. Immunohistochemical staining and Western blot showed the protein levels of myocardial nucleolin in the model group were obviously higher than those in the control group (P<0.05).
CONCLUSION
Nucleolin may play a role in the pathogenesis and development of the diabetic cardiomyopathy.
Animals
;
Blood Glucose
;
Diabetes Mellitus, Experimental
;
metabolism
;
Diabetic Cardiomyopathies
;
metabolism
;
Myocardium
;
pathology
;
Phosphoproteins
;
metabolism
;
RNA-Binding Proteins
;
metabolism
;
Rats
9.Mechanism of changes in intestinal epithelium permeability and its countermeasure after burn injury.
Chinese Journal of Burns 2010;26(5):334-335
After a series of studies, we found that the intestinal permeability was increased, tight junction protein (zonula occluden-1) obviously decreased and redistributed, accompanied by an increase in expression of myosin light chain (MLC) phosphorylation in severely burned rats. After using inhibitor of MLC kinase (ML-9 2 mg/kg) or of Rho-associated kinase (Y-27632 2 mg/kg), above-mentioned changes could be alleviated. Therefore, to regulate the MLC phosphorylation of tight junction protein and perijunctional actin-myosin ring may be one of the key links to lessen the intestinal epithelium permeability after burn injury.
Animals
;
Burns
;
metabolism
;
Intestinal Mucosa
;
metabolism
;
Intestines
;
metabolism
;
Membrane Proteins
;
metabolism
;
Myosin Light Chains
;
metabolism
;
Permeability
;
Phosphoproteins
;
metabolism
;
Phosphorylation
;
Rats
;
Zonula Occludens-1 Protein
;
rho-Associated Kinases
;
metabolism